Peptide record

TPDB45868

Antiviral standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45868
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 12-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
RWLRGLLSGLLR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C66H114N22O14
ANDCEQHIKMFPTYV
L
1439.77
12.70
3
0
6
+3
1.61
0.250
162.50
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
5500
3.82
1
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
0
Q
2
G
0
H
0
I
5
L
0
K
0
M
0
F
0
P
1
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 0 L: 5 K: 0 M: 0 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
12 reviewed residue count
C66H114N22O14 sequence-only estimate (linear, free termini)
1439.77 sequence-only estimate (linear, free termini)
12.70 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
1.61 sequence-only estimate (linear, free termini)
0.250 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0